SARS-CoV-2 Research Study Participants
Company: UT Health
Location: Houston , TX
Category: Clinical Research Studies, General
Job Type: Full Time
Posted: 10/7/2020

Purpose: Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

To assess the efficacy and safety of Human coronavirus immune plasma (HCIP) to reduce the risk of hospitalization or death, the duration of symptoms and duration of nasopharyngeal or oropharyngeal viral shedding.


Condition: SARS-CoV 2

Eligible Ages: Over 18 Years

Eligible Genders: All

Accepts Healthy Volunteers: No

Inclusion Criteria:

  • ≥ 18 years of age
  • Competent and capable to provide informed consent
  • Positive RNA test for presence of SARS-CoV-2 in fluid collected by oropharyngeal or nasopharyngeal swab
  • Experiencing any symptoms of COVID-19 including but not limited to fever(T> 100.5º F), cough, or other COVID associated symptoms like anosmia
  • ≤ 8 days since the first symptoms of COVID-19
  • ≤ 8 days since first positive SARS-CoV-2 RNA test
  • Able and willing to comply with protocol requirements listed in the informed consent

Exclusion Criteria

  • Hospitalized or expected to be hospitalized within 24 hours of enrollment
  • Psychiatric or cognitive illness or recreational drug/alcohol use that in the opinion of the principal investigator, would affect subject safety and/or compliance
  • History of prior reactions to transfusion blood products
  • Inability to complete therapy with the study product within 24 hours after enrollment
  • Receiving any treatment drug for COVID-19 within 14 days prior to screening evaluation (off label like hydroxychloroquine, compassionate use or study trial related)

Houston, TX
Apply Now
This website uses cookies for analytics and to function properly. By using our site, you agree to these terms.